BE1002024A6 - Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. - Google Patents
Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. Download PDFInfo
- Publication number
- BE1002024A6 BE1002024A6 BE8900463A BE8900463A BE1002024A6 BE 1002024 A6 BE1002024 A6 BE 1002024A6 BE 8900463 A BE8900463 A BE 8900463A BE 8900463 A BE8900463 A BE 8900463A BE 1002024 A6 BE1002024 A6 BE 1002024A6
- Authority
- BE
- Belgium
- Prior art keywords
- hecogenin
- treatment
- derivatives
- esters
- benign prostatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3838716A DE3838716A1 (de) | 1988-11-15 | 1988-11-15 | Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1002024A6 true BE1002024A6 (fr) | 1990-05-22 |
Family
ID=6367236
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE8900463A BE1002024A6 (fr) | 1988-11-15 | 1989-04-26 | Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. |
BE8900463A BE1002504A3 (fr) | 1988-11-15 | 1989-04-26 | Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE8900463A BE1002504A3 (fr) | 1988-11-15 | 1989-04-26 | Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5002939A (fr) |
EP (1) | EP0369216B1 (fr) |
JP (1) | JP2562210B2 (fr) |
AT (1) | ATE90563T1 (fr) |
BE (2) | BE1002024A6 (fr) |
DE (2) | DE3838716A1 (fr) |
ES (1) | ES2057054T3 (fr) |
GR (1) | GR3008170T3 (fr) |
IT (1) | IT1229272B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
ID26989A (id) * | 1998-03-26 | 2001-02-22 | Phytopharm Plc | Smilagenin dan anzurogenin-d untuk pengobatan penyakit alzheimer |
US6241987B1 (en) * | 1998-08-20 | 2001-06-05 | Amway Corporation | Dietary supplement containing saw palmetto, pumpkin seed, and nettle root |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US6261607B1 (en) * | 1999-10-19 | 2001-07-17 | Thomas Newmark | Composition for promoting prostate health containing selenium and herbal extracts |
GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
KR101130212B1 (ko) * | 2002-03-27 | 2012-04-13 | 파이토팜 피엘씨 | 사포게닌 및 그 유도체의 치료 방법 및 사용법 |
CA2721665C (fr) | 2008-04-18 | 2017-01-24 | Reata Pharmaceuticals, Inc. | Composes comprenant un pharmacore anti-inflammatoire et procedes d'utilisation |
JPWO2018042825A1 (ja) * | 2016-08-30 | 2019-01-31 | パナソニックIpマネジメント株式会社 | 色変換素子 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2201893A1 (fr) * | 1972-10-06 | 1974-05-03 | American Home Prod | |
DE2759171A1 (de) * | 1977-12-31 | 1979-07-12 | Roecar Holdings Nv | Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor |
GB2024624A (en) * | 1978-07-05 | 1980-01-16 | Roecar Holdings Nv | Anti inflammatory spiroketalins |
EP0285383A2 (fr) * | 1987-04-03 | 1988-10-05 | Merck & Co. Inc. | Traitement des carcinomes prostatiques avec des 17-bêta-n-monosubstitué-carbamoyl-4-aza-5-alpha-androst-1-en-ones |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA582813A (fr) * | 1959-09-08 | Elks Joseph | 3.beta., 12.beta.-DIHYDROXY-11-OXO-23-BROMO-5.alpha., 22.alpha.-SPIROSTAN | |
US3935194A (en) * | 1974-01-22 | 1976-01-27 | Omni Research Incorporated | Separation of hecogenin-tigogenin mixtures |
DE2926463A1 (de) * | 1978-07-05 | 1980-01-24 | Roecar Holdings Nv | Spiroketaline und ihre verwendung |
-
1988
- 1988-11-15 DE DE3838716A patent/DE3838716A1/de active Granted
-
1989
- 1989-04-26 BE BE8900463A patent/BE1002024A6/fr active
- 1989-04-26 BE BE8900463A patent/BE1002504A3/fr not_active IP Right Cessation
- 1989-05-11 IT IT8920466A patent/IT1229272B/it active
- 1989-10-25 ES ES89119837T patent/ES2057054T3/es not_active Expired - Lifetime
- 1989-10-25 EP EP89119837A patent/EP0369216B1/fr not_active Expired - Lifetime
- 1989-10-25 AT AT89119837T patent/ATE90563T1/de not_active IP Right Cessation
- 1989-10-25 DE DE8989119837T patent/DE58904722D1/de not_active Expired - Fee Related
- 1989-11-13 US US07/434,344 patent/US5002939A/en not_active Expired - Lifetime
- 1989-11-15 JP JP1297266A patent/JP2562210B2/ja not_active Expired - Fee Related
-
1993
- 1993-06-17 GR GR930400367T patent/GR3008170T3/el unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2201893A1 (fr) * | 1972-10-06 | 1974-05-03 | American Home Prod | |
DE2759171A1 (de) * | 1977-12-31 | 1979-07-12 | Roecar Holdings Nv | Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor |
GB2024624A (en) * | 1978-07-05 | 1980-01-16 | Roecar Holdings Nv | Anti inflammatory spiroketalins |
EP0285383A2 (fr) * | 1987-04-03 | 1988-10-05 | Merck & Co. Inc. | Traitement des carcinomes prostatiques avec des 17-bêta-n-monosubstitué-carbamoyl-4-aza-5-alpha-androst-1-en-ones |
Also Published As
Publication number | Publication date |
---|---|
EP0369216A3 (en) | 1990-11-07 |
EP0369216A2 (fr) | 1990-05-23 |
BE1002504A3 (fr) | 1991-03-05 |
JP2562210B2 (ja) | 1996-12-11 |
JPH02180830A (ja) | 1990-07-13 |
GR3008170T3 (fr) | 1993-09-30 |
IT1229272B (it) | 1991-07-26 |
ATE90563T1 (de) | 1993-07-15 |
US5002939A (en) | 1991-03-26 |
DE3838716A1 (de) | 1990-05-17 |
ES2057054T3 (es) | 1994-10-16 |
DE58904722D1 (de) | 1993-07-22 |
IT8920466A0 (it) | 1989-05-11 |
EP0369216B1 (fr) | 1993-06-16 |
DE3838716C2 (fr) | 1990-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE875634A (fr) | Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate | |
NO940277L (no) | Triglycerider og blandinger av slike | |
IT8721453A0 (it) | Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche. | |
DE69409969D1 (de) | Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen | |
BE1002024A6 (fr) | Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. | |
ES2017964B3 (es) | Dispositivo de almacenamiento y de distribucion de objetos. | |
SE8903914D0 (sv) | Oral composition for the treatment of inflammatory bowel diseases | |
ATE76747T1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
DE3583008D1 (de) | Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren. | |
DE69328492D1 (de) | Fettsäure-derivate und diese enthaltende pharmazeutische präparationen | |
BR9501404A (pt) | 1H-indol-3 glioxilamida e formulação farmacèutica | |
FR2612187B1 (fr) | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant | |
FR2321892A1 (fr) | Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone | |
MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
MX9101035A (es) | Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene | |
FI932769A0 (fi) | Farmaceutisk komposition med foerbaettrad biotillgaenglighet och innehaollande probukol | |
DE59611383D1 (de) | Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben | |
SE8600496L (sv) | Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider | |
BE887639A (fr) | Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne | |
EP0544802A4 (en) | Methods and compositions for treating t-cell mediated diseases | |
NO933016D0 (no) | Fremgangsmaate for sikker administrering av fettsyre | |
SE8304332L (sv) | Lekemedel med cytostatisk verkan | |
ATE181230T1 (de) | Niedrigviskose kosmetische und pharmazeutische emulsionen | |
FR2682598B1 (fr) | Compositions pharmaceutiques de peptides et procedes pour leur preparation. | |
DE3851938D1 (de) | Polyaromatische Ester von makroliden Antibiotika und linkosamiden Antibiotika, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen und kosmetischen Zusammensetzungen. |